As of 2026-06-28, the EV/EBITDA ratio of Mersana Therapeutics Inc (MRSN) is -1.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRSN's latest enterprise value is 89.01 mil USD. MRSN's TTM EBITDA according to its financial statements is -66.29 mil USD. Dividing these 2 quantities gives us the above MRSN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 17.3x | 17.0x |
| Forward P/E multiples | 17.2x - 22.3x | 20.2x |
| Fair Price | (216.76) - (218.09) | (235.32) |
| Upside | -845.4% - -849.9% | -909.2% |
| Date | EV/EBITDA |